News

Fierce Biotech4h
From ADCs to radiopharma: How AstraZeneca is trying to ‘redefine oncology care’
AstraZeneca has been busy in recent years pumping up its oncology pipeline via a shopping list of assets and companies. | ...
pharmaphorum1dOpinion
AZ, Daiichi get EU okay for breast cancer drug Datroway
AstraZeneca and Daiichi Sankyo have claimed approval from the European Commission for their TROP2-directed antibody-drug ...
The Pharma Letter1d
First approval in the EU for Daiichi Sankyo and AstraZeneca’s Datroway
Datroway (datopotamab deruxtecan) has been approved in the European Union (EU) for the treatment of adult patients with ...
DATROWAY® Approved in the EU for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
DATROWAY® (datopotamab deruxtecan) has been approved in the European Union (EU) for the treatment of adult patients with ...
Zacks Investment Research on MSN2d
AZN Gets EU Nod for Expanded Use of Two Separate Cancer Drugs
AstraZeneca AZN and partner Daiichi Sankyo announced that the European Commission has approved the expanded use of Enhertu ...
Pharmaceutical Technology on MSN1d
Epsilogen acquires TigaTx to expand pan-isotope cancer antibody pipeline
Epsilogen has acquired antibody developer TigaTx in a deal that collates work from the companies’ alternative antibody ...
Daiichi Sankyo, AstraZeneca’s Enhertu approved in European Union
Daiichi Sankyo (DSNKY) and AstraZeneca’s Enhertu has been approved in the European Union as a monotherapy for the treatment of adult patients with unresectable or metastatic hor ...
Seeking Alpha5d
AstraZeneca's metastatic breast cancer treatment gets EU nod
Daiichi Sankyo (TSE: 4568) and AstraZeneca (NASDAQ:AZN) said on Friday that Enhertu received European Union approval for the treatment of adults with advanced metastatic breast cancer. Enhertu is ...
Nasdaq5d
AstraZeneca And Daiichi Sankyo's Enhertu Approved In EU For Advanced Breast Cancer Treatment
(RTTNews) - AstraZeneca Plc. (AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) Enhertu (trastuzumab deruxtecan) has been approved in the European Union as a treatment for adults with advanced breast ...
GlobalData on MSN5d
Daiichi and AstraZeneca’s Enhertu gains EC approval for breast cancers
The European Commission (EC) has approved Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) for use as a ...
Daiichi Sankyo and AstraZeneca secure EU approval for Datroway
(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Tuesday said Datroway has secured EU approval to treat breast cancer patients. Daiichi Sankyo, a Tokyo-based pharmaceutical company, and ...